Skip to main content

Table 1 Data collection procedures

From: Systematic medical assessment, referral and treatment for diabetes care in China using lay family health promoters: protocol for the SMARTDiabetes cluster randomised controlled trial

Assessment description

Screening

Baseline/randomisation

12-month visit

Final visit

Informed consent

X

   

Eligibility

X

X

  

Reasons for non-participation

X

X

  

Demographics, medical history,

 

X

  

Medications, physical examination, vital signs, vital statusa

 

X

X

X

Quality of life questionnaire

 

X

X

X

Laboratory resultsa

 

X

X

X

Serious adverse events

 

X

X

 
  1. aEnd point evaluation data derived from these data elements